News

Point-of-Care Partners Adopts ESOP Ownership: Empowering Employees to Shape the Future of Health IT

HOLLYWOOD, FL / ACCESSWIRE / October 11, 2023 / Point-of-Care Partners (POCP), a prominent leader in Health IT, is thrilled…

2 years ago

Adastra Holdings Provides Corporate Update Following 2023 Growup Awards Victory as Brand of The Year

LANGLEY, BC / ACCESSWIRE / October 11, 2023 / Adastra Holdings Ltd. (CSE:XTRX) (FRA:D2EP) ("Adastra" or the "Company"), a leading…

2 years ago

Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

ORLANDO, FL / ACCESSWIRE / October 11, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal…

2 years ago

Zomedica to Participate in the Lytham Partners Fall 2023 Investor Conference

ANN ARBOR, MI / ACCESSWIRE / October 11, 2023 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary…

2 years ago

Simple HealthKit Partners with Imperial Health Plan of California, Inc. to Provide Comprehensive At-Home Diagnostics Programs to Medicare Advantage Members

Imperial Health selected Simple HealthKit for its ability to deliver high-quality tests, real-time data analytics and a great member experience,…

2 years ago

Visory Health Recognized as Aging 2.0 Optimize Awards Healthcare Impact Winner Creating Healthier Lives for Older Adults

The health tech company is awarded for its instrumental changes in addressing national healthcare challenges for the aging populationESTERO, Fla.,…

2 years ago

Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting

Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently approved by FDA for treatment…

2 years ago

Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…

2 years ago

Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina

-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 -First field tests of stacked…

2 years ago